Get an in-depth insight of
one of the leading biotech investors
BB BIOTECH (SIX)
CHF 30.55
31.03.2025
Share Price Performance YTD
-13.7%
Market capitalisation
CHF 1.7 bn
Net Asset Value (NAV)
CHF 35.55
BB BIOTECH (XETRA)
EUR 31.80
31.03.2025
Share Price Performance YTD
-15.1%
Market capitalisation
EUR 1.8 bn
Net Asset Value (NAV)
EUR 37.15
Argenx SE
16.2%
31.03.2025
Ionis Pharmaceuticals
11.3%
31.03.2025
Alnylam Pharmaceuticals
9.8%
31.03.2025
Neurocrine Biosciences
9.6%
31.03.2025
Vertex Pharmaceuticals
9.2%
31.03.2025
Revolution Medicines
7.4%
31.03.2025
Incyte
6.0%
31.03.2025
Agios Pharmaceuticals
4.9%
31.03.2025
This website uses cookies, which are necessary for the technical operation of the website and which are always set. Other cookies to personalize content and analyze access to our website are only set with your consent. We also share information about your use of our website with our social media, advertising and analytics partners.
More info